Cited 0 times in

116 26

국내 정신분열병 환자에서 항정신병약물 장기지속형 주사제의 과거, 현재 및 향후 가능성

Other Titles
 The Past, Present and Future Possibility of Long-Acting Injectable Antipsychotics in Korean Patients with Schizophrenia 
Authors
 김찬형 ; 노대영 
Citation
 Korean Journal of Psychopharmacology (대한정신약물학회지), Vol.22(suppl) : S64~S72, 2011 
Journal Title
 Korean Journal of Psychopharmacology (대한정신약물학회지) 
ISSN
 1017-5717 
Issue Date
2011
Abstract
Long-acting injectable (LAI) antipsychotics were developed to increase adherence rates in patients requiring maintenance therapy for schizophrenia. Although, evidence was established that LAIs reduce the risk of relapse and rehospitalization, they were underused or misguided by physician for bias and reluctance of patients. Prevalent uses of LAIs were hindered as well by a strict health insurance regulation in Korea. Shared decision-making by both patients and clinicians should be promoted to maximize the potential advantage of LAIs. Large clinical studies are required to develop a broader understanding about pros and cons of LAIs. Advanced and newly-developed LAIs are about to be introduced in Korea in near future and are expected to broaden the treatment choice in schizophrenia. LAIs should be considered as a valuable treatment option in facilitating relapse prevention and optimum outcome.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/95059
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Psychiatry
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
T201105260.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse